Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
a study on Breast Cancer
Node Positive HER2 Negative Breast Cancer Breast Neoplasms Aspirin
Lead Scientists at UC Cancer
- Rita S. Mehta (uci)
Health Sciences Professor, Medicine. Authored (or co-authored) 100 research publications.
- Richard B. Schwab (ucsd)
Dr. Schwab's research focuses on biomarkers to diagnosis and refine the treatment of cancer. His current projects include precision oncology using DNA sequencing, target discovery using RNA sequencing, and validation of novel cancer initiating cell markers.
- Helen K. Chew (ucdavis)
Professor, Hematology and Oncology. Authored (or co-authored) 53 research publications.
- Niharika Dixit (ucsf)
Associate Professor, Medicine. Authored (or co-authored) 15 research publications.
- accepting new patients
- Start Date
- Alliance for Clinical Trials in Oncology
- Phase 3
- Study Type
- Last Updated